Physician-Reported Benefits and Barriers to Clinical Implementation of Genomic Medicine: A Multi-Site IGNITE-Network Survey
Journal of Personalized Medicine – To understand potential barriers and provider attitudes, we surveyed 285 physicians from five Implementing GeNomics In pracTicE (IGNITE) sites about their perceptions as to the clinical utility of genetic data as well as their preparedness to integrate it into practice.
Educational strategies to enable expansion of pharmacogenomics-based care
American Journal of Health-System Pharmacy – This review summarizes requisite pharmacist competencies, educational standards, and the current state of pharmacogenomics education to propose best practice solutions for educators to meet the specific needs and challenges of this complex topic.
IGNITE Network highlighted at Precision Medicine World Conference 2017
BioQuick News – Duke University’s Dr. Geoffrey Ginsburg, co-chair and speaker at the 2017 Precision Medicine World Conference, presented the IGNITE Network’s achievements and aspirations to advance the implementation of genomics in practice.
Institutional profile: University of Florida Health Personalized Medicine Program
Pharmacogenomics – We are contributing to the evidence based on outcomes with genotype-guided therapy through pragmatic studies of our clinical implementations. In addition, we have developed a broad array of educational programs for providers, trainees and students that incorporate personal genotype evaluation to enhance participant learning.
Medical student preparedness for an era of personalized medicine: findings from one US medical school
Personalized Medicine – The objective of this research was to assess medical student preparedness for the use of personalized medicine.
Pharmacogenomics competencies in pharmacy practice: A blueprint for change
Journal of the American Pharmacists Association – Given the rapidly evolving science, educational needs, and practice models in this area, a standardized competency-based approach to pharmacist education and training in pharmacogenomics is needed to equip pharmacists for leadership roles as essential members of healthcare teams that implement clinical utilization strategies for genomic data.
Providing patient education: impact on quantity and quality of family health history collection
Familial Cancer – Patient education improves FHH collection and subsequent risk stratification utilized in providing actionable evidence-based care recommendations for cancer risk management.
Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support
Journal of Personalized Medicine – This study assessed physician attitudes toward adopting genome-guided prescribing through clinical decision support (CDS), prior to enlisting in the Clinical Implementation of Personalized Medicine through Electronic Health Records and Genomics pilot pharmacogenomics project (CLIPMERGE PGx).
Development and preliminary evaluation of an online educational video about whole-genome sequencing for research participants, patients, and the general public
Journal of Community Genetics – Structured interviews, including open-ended and closed-ended questions, were conducted with 205 patients in an inner-city hospital outpatient clinic.
The Genomic Medicine Model: An Integrated Approach to Implementation of Family Health History in Primary Care
Personalized Medicine – As an essential tool for risk stratification, family health history (FHH) is a central component of personalized medicine; yet, despite its widespread acceptance among professional societies and its established place in the medical interview, its widespread adoption is hindered by three major barriers: quality of FHH collection, risk stratification capabilities and interpretation of risk stratification for clinical care.